Literature DB >> 23960923

Choroidal osteoma with CNVM - Successful treatment with intravitreal Bevacizumab.

Guruprasad S Ayachit1, Neeraj Pandey, Vandana Dwivedi.   

Abstract

Twenty-seven years old healthy woman presented with complaints of sudden painless blurred vision in right eye for 1 week. On examination, visual acuity was 20/30 in the right eye and 20/20 in left eye. Fundus examination OS was normal; OD demonstrated a flat, opaque, yellowish parapapillary choroidal lesion with grayish membrane associated with minimal subretinal fluid suggestive of a CNVM in the center. B-scan ultrasonography revealed findings consistent with a choroidal osteoma. Fundus fluorescein angiography of the right eye revealed a relatively well-defined area of hyperfluorescence that increased in size and intensity in the later phases suggestive of active extrafoveal CNVM. Optical coherence tomography confirmed the extrafoveal CNVM with subfoveal fluid. She was treated with intravitreal Bevacizumab OD. At the 2 weeks visit, vision OD improved to 20/20. The FFA and OCT revealed a resolved CNVM. Intravitreal Bevacizumab may be an effective alternative in the management of CNVM secondary to choroidal osteoma.

Entities:  

Keywords:  Bevacizumab; Choroidal neovascular membrane; Optical coherence tomography; Osteoma

Year:  2010        PMID: 23960923      PMCID: PMC3729878          DOI: 10.1016/j.sjopt.2010.11.005

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  8 in total

1.  Regression of extrafoveal choroidal osteoma following photodynamic therapy.

Authors:  Carol L Shields; Miguel A Materin; Sonul Mehta; Brett T Foxman; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2008-01

2.  Intravitreal ranibizumab in a patient with choroidal neovascularization secondary to choroidal osteoma.

Authors:  M-h Song; Y-j Roh
Journal:  Eye (Lond)       Date:  2008-10-24       Impact factor: 3.775

Review 3.  Choroidal osteoma.

Authors:  C L Shields; J A Shields; J J Augsburger
Journal:  Surv Ophthalmol       Date:  1988 Jul-Aug       Impact factor: 6.048

Review 4.  Choroidal osteoma.

Authors:  E F Kadrmas; J J Weiter
Journal:  Int Ophthalmol Clin       Date:  1997

5.  A long-term follow-up of choroidal osteoma.

Authors:  G W Aylward; T S Chang; S E Pautler; J D Gass
Journal:  Arch Ophthalmol       Date:  1998-10

6.  Choroidal Osteoma.

Authors:  J D Gass; R K Guerry; R L Jack; G Harris
Journal:  Arch Ophthalmol       Date:  1978-03

7.  Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).

Authors:  Hamid Ahmadieh; Nasser Vafi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-25       Impact factor: 3.117

8.  Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.

Authors:  R Narayanan; V A Shah
Journal:  Eur J Ophthalmol       Date:  2008 May-Jun       Impact factor: 2.597

  8 in total
  2 in total

1.  Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma.

Authors:  V P Papastefanou; M Pefkianaki; L Al Harby; A K Arora; V M L Cohen; R M Andrews; M S Sagoo
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

2.  Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.

Authors:  Ahmad M Mansour; J Fernando Arevalo; Eman Al Kahtani; Hernando Zegarra; Emad Abboud; Rajiv Anand; Hamid Ahmadieh; Robert A Sisk; Salman Mirza; Samuray Tuncer; Amparo Navea Tejerina; Jorge Mataix; Francisco J Ascaso; Jose S Pulido; Rainer Guthoff; Winfried Goebel; Young Jung Roh; Alay S Banker; Ronald C Gentile; Isabel Alonso Martinez; Rodney Morris; Neeraj Panday; Park Jung Min; Emilie Mercé; Timothy Y Y Lai; Vicky Massoud; Nicola G Ghazi
Journal:  J Ophthalmol       Date:  2014-07-23       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.